SLC19A3 (NM_025243) Human Mass Spec Standard
CAT#: PH306409
SLC19A3 MS Standard C13 and N15-labeled recombinant protein (NP_079519)
View other "SLC19A3" proteins (3)
Need it in bulk or customized? Get a free quote |
CNY 19,520.00
Specifications
Product Data | |
Description | SLC19A3 MS Standard C13 and N15-labeled recombinant protein (NP_079519) |
Species | Human |
Expression Host | HEK293 |
Expression cDNA Clone or AA Sequence | RC206409 |
Predicted MW | 55.7 kDa |
Protein Sequence |
>RC206409 protein sequence
Red=Cloning site Green=Tags(s) MDCYRTSLSSSWIYPTVILCLFGFFSMMRPSEPFLIPYLSGPDKNLTSAEITNEIFPVWTYSYLVLLLPV FVLTDYVRYKPVIILQGISFIITWLLLLFGQGVKTMQVVEFFYGMVTAAEVAYYAYIYSVVSPEHYQRVS GYCRSVTLAAYTAGSVLAQLLVSLANMSYFYLNVISLASVSVAFLFSLFLPMPKKSMFFHAKPSREIKKS SSVNPVLEETHEGEAPGCEEQKPTSEILSTSGKLNKGQLNSLKPSNVTVDVFVQWFQDLKECYSSKRLFY WSLWWAFATAGFNQVLNYVQILWDYKAPSQDSSIYNGAVEAIATFGGAVAAFAVGYVKVNWDLLGELALV VFSVVNAGSLFLMHYTANIWACYAGYLIFKSSYMLLITIAVFQIAVNLNVERYALVFGINTFIALVIQTI MTVIVVDQRGLNLPVSIQFLVYGSYFAVIAGIFLMRSMYITYSTKSQKDVQSPAPSENPDVSHPEEESNI IMSTKL TRTRPLEQKLISEEDLAANDILDYKDDDDKV |
Tag | C-Myc/DDK |
Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Concentration | >0.05 µg/µL as determined by microplate BCA method |
Labeling Method | Labeled with [U- 13C6, 15N4]-L-Arginine and [U- 13C6, 15N2]-L-Lysine |
Buffer | 25 mM Tris-HCl, 100 mM glycine, pH 7.3 |
Reference Data | |
RefSeq | NP_079519 |
RefSeq Size | 3775 |
RefSeq ORF | 1488 |
Synonyms | BBGD; THMD2; thTr-2; THTR2 |
Locus ID | 80704 |
Cytogenetics | 2q36.3 |
Summary | This gene encodes a ubiquitously expressed transmembrane thiamine transporter that lacks folate transport activity. Mutations in this gene cause biotin-responsive basal ganglia disease (BBGD); a recessive disorder manifested in childhood that progresses to chronic encephalopathy, dystonia, quadriparesis, and death if untreated. Patients with BBGD have bilateral necrosis in the head of the caudate nucleus and in the putamen. Administration of high doses of biotin in the early progression of the disorder eliminates pathological symptoms while delayed treatment results in residual paraparesis, mild cognitive disability, or dystonia. Administration of thiamine is ineffective in the treatment of this disorder. Experiments have failed to show that this protein can transport biotin. Mutations in this gene also cause a Wernicke's-like encephalopathy.[provided by RefSeq, Jan 2010] |
Protein Families | Transmembrane |
Documents
FAQs |
SDS |
Resources
蛋白相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
LC410805 | SLC19A3 HEK293T cell transient overexpression lysate (as WB positive control) |
CNY 900.00 |
|
LY410805 | Transient overexpression lysate of solute carrier family 19, member 3 (SLC19A3) |
CNY 3,080.00 |
|
TP306409 | Recombinant protein of human solute carrier family 19, member 3 (SLC19A3), 20 µg |
CNY 2,900.00 |
其它SLC19A3产品